Watchlist Price Alert

Serina Therapeutics Inc. (SER)

NYSE: SER · Real-Time Price · USD

5.79

0.48 (9.04%)

At close: May 02, 2025, 3:59 PM

5.79

-0.13%

After-hours: May 02, 2025, 03:59 PM EDT

Serina Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	3.67M	345K	532.23K	314.85K	527K	2.35M	6.71M	7.38M	259K
Short-Term Investments	n/a	n/a	n/a	996.45K	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	10.6M	50K	50K	50K	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-50K	-50K	1.59M	2.26M	2.73M	1.91M	2.34M
Receivables	n/a	n/a	n/a	1.11K	326K	363K	131K	107K	308K
Inventory	n/a	n/a	-1.79M	-1.61M	n/a	n/a	n/a	n/a	n/a
Other Current Assets	77K	352K	n/a	n/a	1.43M	1.34M	1.01M	111K	121K
Total Current Assets	5.68M	754K	548.58K	1.33M	2.28M	4.05M	7.85M	7.59M	688K
Property-Plant & Equipment	1.05M	n/a	309.47K	514.15K	n/a	1.13M	90K	129K	195K
Goodwill & Intangibles	n/a	607K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.05M	11.21M	309.47K	514.15K	1.64M	3.39M	2.82M	2.04M	2.54M
Total Assets	6.72M	11.96M	858.04K	1.84M	3.92M	7.44M	10.67M	9.63M	3.22M
Account Payables	744K	580K	143.34K	145.47K	761K	420K	150K	75K	261K
Deferred Revenue	n/a	n/a	153.5K	n/a	275K	283K	317K	180K	264K
Short-Term Debt	n/a	3.67M	n/a	n/a	2.4M	428K	n/a	n/a	n/a
Other Current Liabilities	1.06M	829K	n/a	n/a	1.93M	2.17M	1.97M	1.06M	25.07M
Total Current Liabilities	2.37M	5.91M	437.69K	371.47K	5.36M	3.3M	2.44M	1.31M	25.6M
Long-Term Debt	n/a	693K	1.62M	n/a	3.9M	1.53M	n/a	n/a	n/a
Other Long-Term Liabilities	3.58M	n/a	36.52M	36.39M	-1	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	3.85M	693K	38.2M	36.58M	3.96M	1.53M	n/a	n/a	n/a
Total Liabilities	6.22M	6.61M	38.64M	36.95M	9.32M	4.83M	2.44M	1.31M	25.6M
Total Debt	268K	4.37M	1.81M	398.17K	6.3M	1.96M	n/a	n/a	n/a
Common Stock	1K	n/a	22.18K	21.45K	4K	4K	4K	3K	3K
Retained Earnings	-44.32M	-131.01M	-38.45M	-35.76M	-97.07M	-86.21M	-74.05M	-66.55M	-59.97M
Comprehensive Income	n/a	n/a	n/a	n/a	143K	69K	-2K	68K	58K
Shareholders Equity	641K	5.47M	-37.78M	-35.11M	-5.12M	2.22M	7.45M	7.28M	-23.42M
Total Investments	n/a	10.6M	50K	996.45K	50K	n/a	n/a	n/a	n/a